During the past decade, Klinikum Bogenhausen conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Bogenhausen" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials, followed by "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials sponsored, "LivaNova" with 3 trials sponsored, "Munich Municipal Hospital" with 3 trials sponsored and "Stiftung Institut fuer Herzinfarktforschung" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bogenhausen" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Avania" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "BARMER" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Bogenhausen" are "Coronary Artery Disease" (3 trials), "Arrhythmia" (2 trials), "Atrial Fibrillation" (2 trials), "Cholangiocarcinoma" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Klinikum Bogenhausen" in a lesser frequency.

Most popular intervention types in "Klinikum Bogenhausen" are "Drug" (17 trials), "Device" (13 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (3 trials), "Placebo" (3 trials), "Clopidogrel" (2 trials), "Gemcitabine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bogenhausen" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Bogenhausen". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Klinikum Bogenhausen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bogenhausen, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 8 trials that are defined as “Not Applicable".